The revenue miss and reduced EBITDA guidance suggest continued margin pressure and demand softness. Monitor Q3 2026 case volume trends and the impact of the new AlloClae partnership on revenue per case. The extended term loan maturity and required $2.5M payment by Sept 30, 2026, add near-term liquidity focus.
Price Chart
Executive Summary
AirSculpt reported Q2 2026 revenue of $42.9M, down 3% YoY and below the $44.1M consensus estimate, with a GAAP EPS loss of -$0.02 vs consensus of +$0.02. The company reaffirmed full-year 2026 revenue at the lower end of its $151-157M guidance range but reduced its adjusted EBITDA outlook to $12-14M. Despite stable same-center case volume and debt reduction, the revenue miss and lowered EBITDA guidance signal ongoing operational challenges and margin compression, making this a bearish report for a company with a $353M market cap.
Key Financial Metrics
Key Facts
- Q2 2026 revenue of $42.9M declined 3% YoY from $44.0M, missing consensus of $44.1M
- GAAP EPS of -$0.02 missed consensus estimate of +$0.02 (a -150% surprise)
- Net loss widened to -$1.1M from -$0.6M in Q2 2025
- Adjusted EBITDA fell to $4.9M from $5.8M YoY, with margin compressing to 11.5% from 13.3%
- Full-year 2026 revenue guidance reaffirmed at lower end of $151-157M range; adjusted EBITDA outlook reduced to $12-14M
- Case volume declined 0.5% to 3,376; revenue per case fell 2.0% to $12,707
- Gross debt reduced ~$30M to $44.2M; cash increased ~$10M to $18.8M; term loan maturity extended to Nov 2027
- Raised $5.0M from at-the-market offering in Q2; paid down $1.4M of debt
Financial Impact
Revenue miss of ~$1.2M (2.7% below consensus) and lowered EBITDA guidance by ~$2M at midpoint
Risk Factors
- Continued revenue decline and margin compression if case volume and revenue per case do not stabilize
- Potential dilution from at-the-market equity offerings (50% of net proceeds required for debt prepayment under amended term loan)
- Increased competition from weight-loss drugs and alternative body contouring treatments
- Liquidity risk with $5.0M revolver capacity and $2.5M mandatory debt payment due Sept 30, 2026
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3341632 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 15, 2026 10w ago | Institutional Cluster | $3.09 $2.13 | ▼ −30.96% | ▼ −28.98% | $1.24 (−59.81%) |
Aug 10, 2026 11w ago | 8-K | $2.75 $2.71 | ▲ +1.64% | ▲ +0.72% | $1.24 (+54.91%) |
Aug 10, 2026 11w ago | Press Release | $2.75 $2.71 | ▲ +1.64% | ▲ +0.72% | $1.24 (+54.91%) |
May 8, 2026 24w ago | 8-K | $3.86 $5.11 | ▲ +32.38% | ▲ +32.36% | $1.24 (−67.88%) |
May 8, 2026 24w ago | Press Release | $3.86 $5.11 | ▼ −32.38% | ▼ −32.36% | $1.24 (+67.88%) |
May 1, 2026 25w ago | Press Release | $3.32 $5.30 | ▲ +59.64% | ▲ +54.35% | $1.24 (−62.65%) |
Apr 6, 2026 29w ago | 10-K/A | $3.10 $3.44 | ▼ −10.97% | ▼ −1.98% | $1.24 (+60.00%) |
Apr 6, 2026 29w ago | Press Release | $3.10 $3.44 | ▼ −10.97% | ▼ −1.98% | $1.24 (+60.00%) |
Apr 2, 2026 29w ago | 8-K | $3.17 $2.68 | ▲ +15.46% | ▲ +25.33% | $1.24 (+60.88%) |
Apr 2, 2026 29w ago | Press Release | $3.17 $2.68 | ▲ +15.46% | ▲ +25.33% | $1.24 (+60.88%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers